Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.
Fiche publication
Date publication
août 2019
Journal
World journal of gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BEN ABDELGHANI Meher, Pr BOUCHE Olivier
Tous les auteurs :
Bouché O, Ben Abdelghani M, Labourey JL, Triby S, Bensadoun RJ, Jouary T, Des Guetz G
Lien Pubmed
Résumé
Anti-epidermal growth factor receptor therapy is associated with skin adverse events not previously reported with conventional chemotherapy. Prophylactic actions are recommended, but routine clinical management of these toxicities and their impact on quality of life remain unknown.
Mots clés
Epidermal growth factor receptor inhibitors, Metastatic colorectal cancer, Panitumumab, Quality of life, Skin toxicity
Référence
World J. Gastroenterol.. 2019 Aug 7;25(29):4007-4018